HealthSonix Announces ZingiberRx Joint and Muscle Cream Marketing Program Soaring
Wednesday February 27, 11:14 am ET
IRVINE, Calif.--(BUSINESS WIRE)--HealthSonix, Inc. (OTC:HSXI)(FWB:H7S) today announced that the multi-faceted marketing program for ZingiberRx Joint and Muscle Cream launched earlier this month is hitting stride and exceeding company expectations. The program consisted of launching the website, sampling, direct to consumer sales, test markets in retail stores, and advertising on Google search engines.
“Yesterday alone, we had over 5,300 visits to our website and received over 5,000 requests for samples,“ said Dieter D. Doederlein, Vice President of Corporate Development for HealthSonix. “This is significant because early evidence suggests that we have a high conversion rate from sample to purchase, and we continue to get positive feedback from users of all ages.”
“In addition to the direct to consumer marketing efforts, we have been test marketing the product in regional drug stores and have now progressed to Vendor status with one of the largest national drug store chains in Canada. ZingiberRx is actually the number one selling topical pain reliever in many of the early test locations and we have the full support and participation of the pharmacists when it comes to explaining the product and its benefits,” added Doederlein.
“The response to this new pain relieving cream, the first of its kind with ginger, is just short of amazing. It is really rewarding to witness the instant acceptance of ZingiberRx for the relief of pain and inflammation.”
ZingiberRx joint and muscle cream is fast acting, non-staining, fast absorbing, and deep penetrating. Unlike most over-the-counter topical ointments, ZingiberRx is not a counter-irritant and does not create a hot or a cold sensation when applied.
Medical research studies into the medicinal properties of various plants in the ginger (Zingiberaceae) family have isolated the Zingiber cassumunar species for its anti-inflammatory, anti-allergic and pain relieving properties.
HealthSonix, Inc. (OTC:HSXI)(FWB:H7S) is a publicly traded research oriented medical technology company that develops and markets medical devices and healthcare products for institutional and consumer use. The company’s patent pending medical devices deliver sound pressure waves to the human body for relief of pain and other musculoskeletal conditions. The focus is on arthritis, athletic injuries and conditions where acute or chronic pain is the cardinal symptom.
More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
Note: A number of statements contained in this news release are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
Dieter D. Doederlein, 905-212-7711